-
Lenvatinib combined with immune checkpoint inhibitors for unresectable, recurrent, or metastatic hepatocellular carcinoma: a real-world stud
Author: Kong, Huifang; Chen, Yan; Li, Hong; Wang, Di; Chang, Xiujuan; Zeng, Zhen; Zhang, Wei
Journal: ONCOLOGIST. 2026; Vol. 31, Issue 5, pp. -. DOI: 10.1093/oncolo/oyag097
-
Dynamic cytogenetic evolution in multiple myeloma: prognostic implications from diagnosis to first relaps
Author: Chen, Qi; Tian, Tian; Shi, Yu; Shen, Xuxing; Qiu, Hairong; Jin, Yuanyuan; Chen, Lijuan; Guo, Rui
Journal: ONCOLOGIST. 2026; Vol. 31, Issue 5, pp. -. DOI: 10.1093/oncolo/oyag105
-
Low opinion of generic oral anticancer drugs: an unacknowledged factor resulting in medication waste in Chin
Author: Wang, Yan; Song, Hongwei; Cao, Jinming; Chen, Zhicong; Xu, Feng
Journal: ONCOLOGIST. 2026; Vol. 31, Issue 5, pp. -. DOI: 10.1093/oncolo/oyag057
-
Association of IDH1 mutations with survival and recurrence in resected intrahepatic cholangiocarcinoma received or not received adjuvant chemotherap
Author: Wang, Pengcheng; Li, Ning; Ye, Yuhang; Pu, Jing; Sun, Rongqi; Luo, Chubin; Hu, Zhiqiang; Zhou, Zhengjun; Li, Jia; Zou, Jixue; Fan, Jia; Zhou, Jian; Zhou, Shaolai
Journal: ONCOLOGIST. 2026; Vol. 31, Issue 5, pp. -. DOI: 10.1093/oncolo/oyag124
-
Treatment strategies for small cell carcinoma of the esophagus: comparative analysis of multimodal regimens in two independent real-world cohort
Author: Yin, Xiaolei; Li, Xiaopeng; Mi, Lili; Hou, Jiaojiao; Yin, Fei
Journal: ONCOLOGIST. 2026; Vol. 31, Issue 5, pp. -. DOI: 10.1093/oncolo/oyag115
-
The efficacy of sequential radiotherapy after the combination of TACE with lenvatinib and anti-PD-1 antibodies for unresectable HC
Author: Ou, Xiangye; Li, Jinhai; Pan, Rongjian; Liu, Deyi; Wu, Jiayi; Liang, Dong; Li, Yinan; Zeng, Zhenxin; Li, Han; Zhang, Yuxuan; Wu, Junyi; Yan, Maolin
Journal: ONCOLOGIST. 2026; Vol. 31, Issue 5, pp. -. DOI: 10.1093/oncolo/oyag138
-
Predictive modeling of treatment-related thyroid dysfunction and prognostic implication in advanced nasopharyngeal carcinoma with PD-1 inhibitor
Author: Hu, Yubin; Hong, Xinyi; Li, Yi; Zhang, Honghong; Warsi, Mohammad Abidullah; Chen, Ronghui; Lin, Chaoying; Ou, Peidong; Lin, Cuibo; Qiu, Sufang
Journal: ONCOLOGIST. 2026; Vol. 31, Issue 4, pp. -. DOI: 10.1093/oncolo/oyag066
-
Construction of a predictive model based on the risk of relapse after cytarabine consolidation therapy in acute myeloid leukemia patient
Author: Ji, Min; Hao, Yiping; Li, Wei; Zhou, Ying; Jia, Ruinan; Li, Wei; Jin, Shumin; Dai, Min; Chang, Mengyuan; Feng, Lei; Liu, Tingting; Zhang, Di; Ji, Chunyan; Ye, Jingjing
Journal: ONCOLOGIST. 2026; Vol. 31, Issue 4, pp. -. DOI: 10.1093/oncolo/oyag088